AVEENO CLEAR COMPLEXION DAILY CLEANSING PADS- salicylic acid cloth

Aveeno Clear Complexion Daily Cleansing Pads by

Drug Labeling and Warnings

Aveeno Clear Complexion Daily Cleansing Pads by is a Otc medication manufactured, distributed, or labeled by Johnson & Johnson Consumer Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

Salicylic Acid 0.6%

Purpose

Acne treatment

Use

For the treatment of acne.

Warnings

For external use only.

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
• avoid contact with eyes. If contact occurs, flush thoroughly with water.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Gently massage product all over face avoiding eye area; rinse face thoroughly after use.
• Recommended for daily use.
• If bothersome dryness or peeling occurs, reduce application to once a day or even every other day.

Other information

Store at room temperature.

Inactive ingredients

Water, Glycerin, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, PEG-16 Soy Sterol, Polysorbate 20, Sodium Benzoate, Phenoxyethanol, Fragrance, Disodium EDTA, Butylene Glycol, Sodium Hydroxide, Glycine Soja (Soybean) Protein

Questions?

866-428-3366; Outside US, dial collect 215-273-8755 www.aveeno.com

SPL UNCLASSIFIED SECTION

Distributed by:
JOHNSON & JOHNSON
CONSUMER INC.
Skillman, NJ 08558

PRINCIPAL DISPLAY PANEL - 28 Pad Jar Label

DERMATOLOGIST RECOMMENDED
Aveeno ®
CLEAR COMPLEXION
daily cleansing pads
exfoliate + polish
salicylic acid acne treatment
CLEANSE
28 - 3.25" pads
self-foaming dual-textured pads

INGREDIENTS AND APPEARANCE

AVEENO CLEAR COMPLEXION DAILY CLEANSING PADS 
salicylic acid cloth

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69968-0597
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	6 mg

Inactive Ingredients
Ingredient Name	Strength
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
PEG-16 SOY STEROL (UNII: 9J0FEN30IT)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
SODIUM BENZOATE (UNII: OJ245FE5EU)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SOY PROTEIN (UNII: R44IWB3RN5)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69968-0597-1	28 in 1 JAR; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug	08/24/2020	06/25/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333D	08/24/2020	06/25/2024

Labeler - Johnson & Johnson Consumer Inc. (118772437)